BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27099149)

  • 1. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
    Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
    Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
    Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
    Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
    Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
    J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
    PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4+ or to CD8+ T cells.
    Marlies A; Udo G; Juergen B; Bernd S; Herrmann M; Haas JP
    Autoimmunity; 2007 Jun; 40(4):299-301. PubMed ID: 17516214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin.
    Kinjyo I; Gordon SM; Intlekofer AM; Dowdell K; Mooney EC; Caricchio R; Grupp SA; Teachey DT; Rao VK; Lindsten T; Reiner SL
    J Immunol; 2010 Dec; 185(12):7151-5. PubMed ID: 21076068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation.
    Setoguchi R; Matsui Y; Mouri K
    Eur J Immunol; 2015 Mar; 45(3):893-902. PubMed ID: 25476730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.
    Maccari ME; Fuchs S; Kury P; Andrieux G; Völkl S; Bengsch B; Lorenz MR; Heeg M; Rohr J; Jägle S; Castro CN; Groß M; Warthorst U; König C; Fuchs I; Speckmann C; Thalhammer J; Kapp FG; Seidel MG; Dückers G; Schönberger S; Schütz C; Führer M; Kobbe R; Holzinger D; Klemann C; Smisek P; Owens S; Horneff G; Kolb R; Naumann-Bartsch N; Miano M; Staniek J; Rizzi M; Kalina T; Schneider P; Erxleben A; Backofen R; Ekici A; Niemeyer CM; Warnatz K; Grimbacher B; Eibel H; Mackensen A; Frei AP; Schwarz K; Boerries M; Ehl S; Rensing-Ehl A
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33170215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers.
    Roberts CA; Ayers L; Bateman EA; Sadler R; Magerus-Chatinet A; Rieux-Laucat F; Misbah SA; Ferry BL
    Hum Immunol; 2013 Dec; 74(12):1531-5. PubMed ID: 23993982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 Influence mTOR to Modulate CD8
    Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
    Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
    [No Abstract]   [Full Text] [Related]  

  • 14. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
    Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
    Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
    Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
    Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A
    J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells.
    Henson SM; Franzese O; Macaulay R; Libri V; Azevedo RI; Kiani-Alikhan S; Plunkett FJ; Masters JE; Jackson S; Griffiths SJ; Pircher HP; Soares MV; Akbar AN
    Blood; 2009 Jun; 113(26):6619-28. PubMed ID: 19406987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal integration by Akt regulates CD8 T cell effector and memory differentiation.
    Kim EH; Sullivan JA; Plisch EH; Tejera MM; Jatzek A; Choi KY; Suresh M
    J Immunol; 2012 May; 188(9):4305-14. PubMed ID: 22467649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
    Staron MM; Gray SM; Marshall HD; Parish IA; Chen JH; Perry CJ; Cui G; Li MO; Kaech SM
    Immunity; 2014 Nov; 41(5):802-14. PubMed ID: 25464856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
    Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
    Front Immunol; 2019; 10():1193. PubMed ID: 31191551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.